ClinicalTrials.govpublic full text
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
retinitis pigmentosa, modified gene therapy, rho, rp, nr2e3, subretinal injection, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 841993
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.